This study describes the differentially expressed microRNA and circRNA in normal and Zbtb1-deficient EL4 cell lines, thus providing potential targets for drug development and clinical treatment of T-cell lymphoma. Here, ZBTB1 is linked to T-cell non-Hodgkin lymphoma.